[图书][B] Mixed effects models for the population approach: models, tasks, methods and tools

M Lavielle - 2014 - books.google.com
Wide-Ranging Coverage of Parametric Modeling in Linear and Nonlinear Mixed Effects
Models Mixed Effects Models for the Population Approach: Models, Tasks, Methods and …

Parameter estimation in nonlinear mixed effect models using saemix, an R implementation of the SAEM algorithm

E Comets, A Lavenu, M Lavielle - Journal of Statistical Software, 2017 - jstatsoft.org
The saemix package for R provides maximum likelihood estimates of parameters in
nonlinear mixed effect models, using a modern and efficient estimation algorithm, the …

Population pharmacokinetics and B ayesian estimation of tacrolimus exposure in paediatric liver transplant recipients

N Kassir, L Labbé, JR Delaloye… - British journal of …, 2014 - Wiley Online Library
Aims The objectives of this study were to develop a population pharmacokinetic (PopPK)
model for tacrolimus in paediatric liver transplant patients and determine optimal sampling …

Modelling of atorvastatin pharmacokinetics and the identification of the effect of a BCRP polymorphism in the Japanese population

N Tsamandouras, Y Guo, T Wendling… - Pharmacogenetics …, 2017 - journals.lww.com
Aim Ethnicity plays a modulating role in atorvastatin pharmacokinetics (PK), with Asian
patients reported to have higher exposure compared with Caucasians. Therefore, it is …

Clinical trial simulation to evaluate power to compare the antiviral effectiveness of two hepatitis C protease inhibitors using nonlinear mixed effect models: a viral …

C Laouénan, J Guedj, F Mentré - BMC Medical Research Methodology, 2013 - Springer
Background Models of hepatitis C virus (HCV) kinetics are increasingly used to estimate and
to compare in vivo drug's antiviral effectiveness of new potent anti-HCV agents. Viral kinetic …

Uncertainty Computation at Finite Distance in Nonlinear Mixed Effects Models—a New Method Based on Metropolis-Hastings Algorithm

M Guhl, J Bertrand, L Fayette, F Mercier, E Comets - The AAPS Journal, 2024 - Springer
The standard errors (SE) of the maximum likelihood estimates (MLE) of the population
parameter vector in nonlinear mixed effect models (NLMEM) are usually estimated using the …

New model–based bioequivalence statistical approaches for pharmacokinetic studies with sparse sampling

F Loingeville, J Bertrand, TT Nguyen, S Sharan… - The AAPS journal, 2020 - Springer
In traditional pharmacokinetic (PK) bioequivalence analysis, two one-sided tests (TOST) are
conducted on the area under the concentration-time curve and the maximal concentration …

Evaluation of approaches to deal with low-frequency nuisance covariates in population pharmacokinetic analyses

CV Lagishetty, SB Duffull - The AAPS journal, 2015 - Springer
Clinical studies include occurrences of rare variables, like genotypes, which due to their
frequency and strength render their effects difficult to estimate from a dataset. Variables that …

Impact of model misspecification on model-based tests in PK studies with parallel design: real case and simulation studies

M Guhl, F Mercier, C Hofmann, S Sharan… - … of Pharmacokinetics and …, 2022 - Springer
This article evaluates the performance of pharmacokinetic (PK) equivalence testing between
two formulations of a drug through the Two-One Sided Tests (TOST) by a model-based …

Comparison of nonlinear mixed effects models and noncompartmental approaches in detecting pharmacogenetic covariates

A Tessier, J Bertrand, M Chenel, E Comets - The AAPS Journal, 2015 - Springer
Genetic data is now collected in many clinical trials, especially in population
pharmacokinetic studies. There is no consensus on methods to test the association between …